CenteringPregnancy
Behavioral8-12 pregnant women whose due dates are in the same month will receive ten 2-hour group prenatal care sessions according to the standard curriculum provided by the Centering Healthcare Institute.
NCT Number: NCT02640638
The purpose of this study is to evaluate whether CenteringPregnancy group prenatal care can improve preterm birth rate and other birth outcomes, maternal psychosocial and behavioral outcomes, and decrease the racial difference in selected birth outcomes among African American and White women, compared to individual prenatal care.
Looking for future studies?
Notify Me14 year–45 year
Female
Interventional
Not applicable
UCLA, Los Angeles, California, United States
This is a randomized controlled trial to compare biomedical, behavioral and psychosocial outcomes by race among pregnant women who participate in CenteringPregnancy group prenatal care, to women in the traditional individual prenatal care and to investigate whether improving women's stress, activation and engagement will explain the potential benefits of CenteringPregnancy on outcomes and health disparities. The trial will be conducted in a large prenatal care center in South Carolina. Eligible White and Black women will be recruited before 20 weeks of gestational age with low risk pregnancy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
8-12 pregnant women whose due dates are in the same month will receive ten 2-hour group prenatal care sessions according to the standard curriculum provided by the Centering Healthcare Institute.
Time frame: Measured at delivery
Delivery before 37 weeks gestation
Time frame: Measured at delivery
Infant weight (in grams) a birth
Time frame: Measured at delivery
Five criteria used to summarize the health of newborn children: Appearance, Pulse, Grimace, Activity, Respiration
Time frame: Measured at delivery
Weight gained during pregnancy as compared to medical recommendation
Time frame: Measured during pregnancy
Diabetes (occurred during pregnancy (two steps: 50-g GLT (nonfasting) with PG measurement at 1 h (Step 1), at 24-28 wks in women not previously diagnosed with overt diabetes If PG at 1 h after load is ≥140 mg/dL (7.8 mmol/L), proceed to 100-g OGTT (Step 2), performed while patient is fasting GDM diagnosis made when two or more PG levels meet or exceed: Fasting: 95 mg/dL or 105 mg/dL (5.3/5.8)
Time frame: Measured during pregnancy
Hypertension (SBP/DBP: above 140/90 mm Hg) occurred during pregnancy according to medical chart
Time frame: Measured at <20 week and 32-36 week of gestational age
Based on self-reported questionnaire
Clemson University
Other
Reducing Disparities in Birth Outcomes: a Randomized Controlled Trial of CenteringPregnancy
Acronym: CRADLE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07695467
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Sivas, Kayseri Ave, Turkey (Türkiye)
View Trial DetailsNCT01222247
Female Urogenital Diseases and Pregnancy Complications, Lung Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03480139
Death, Female Urogenital Diseases and Pregnancy Complications
Detroit, Michigan, United States
View Trial DetailsNCT00340002
Female Urogenital Diseases and Pregnancy Complications, Fetal Growth Abnormalities
Detroit, Michigan, United States
View Trial Details